APUS · Apimeds Pharmaceuticals US Inc.
AI read · Good for APUS
The AI's read
This gives Apimeds a way to earn development fees through its wholly owned subsidiary. The exclusive provider role adds a defined work stream. Later operating fees are not set, and token allocation depends on a launch. The work also depends on milestones and acceptance tests. MindWave's earlier AQUAE contract adds another paid project, but a possible longer extension needs a separate agreement.